MicroTech Medical (Hangzhou) Co., Ltd.

SEHK:2235 Stock Report

Market Cap: HK$1.7b

MicroTech Medical (Hangzhou) Past Earnings Performance

Past criteria checks 0/6

MicroTech Medical (Hangzhou) has been growing earnings at an average annual rate of 5.2%, while the Medical Equipment industry saw earnings growing at 12.3% annually. Revenues have been growing at an average rate of 30.2% per year.

Key information

5.2%

Earnings growth rate

20.0%

EPS growth rate

Medical Equipment Industry Growth13.7%
Revenue growth rate30.2%
Return on equity-6.1%
Net Margin-49.4%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans

Sep 22
MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans

News Flash: One MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235) Analyst Has Been Trimming Their Revenue Forecasts

Jan 20
News Flash: One MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235) Analyst Has Been Trimming Their Revenue Forecasts

MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans

Jan 18
MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans

Revenue & Expenses Breakdown
Beta

How MicroTech Medical (Hangzhou) makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:2235 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23253-12525770
30 Sep 23233-8523069
30 Jun 23213-4620169
31 Mar 23193-4018165
31 Dec 22174-3516261
30 Sep 22169-3613154
30 Jun 22164-3710246
31 Mar 22158-439941
31 Dec 21151-489536
31 Dec 2075-12110182
31 Dec 1952-796150

Quality Earnings: 2235 is currently unprofitable.

Growing Profit Margin: 2235 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 2235 is unprofitable, but has reduced losses over the past 5 years at a rate of 5.2% per year.

Accelerating Growth: Unable to compare 2235's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 2235 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-10.4%).


Return on Equity

High ROE: 2235 has a negative Return on Equity (-6.07%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.